Target intelligence / Profile preview

Long intergenic non-protein coding RNA 445 (LINC00445)

Target
LINC00445
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

LINC00445 is a human long intergenic non-protein coding RNA gene that does not encode a protein but rather produces a non-coding RNA transcript greater than 200 nucleotides. It is autonomously transcribed from intergenic regions in the genome[3]. Like other lincRNAs, LINC00445 is believed to participate in the fine regulation of gene expression, potentially by interacting with chromatin, regulatory proteins, and RNA molecules. Expression profiling and integrative bioinformatics studies suggest LINC00445 is differentially expressed in cancer tissues, notably lung cancer, where it may serve as a diagnostic biomarker and molecular target in tumorigenesis[2][1]. While its specific biological pathways remain under investigation, the broad family of lincRNAs is known for tissue-specific regulatory roles and involvement in disease pathogenesis[3][5]. There is currently no evidence for misspelling, ambiguity, or incorrect annotation regarding LINC00445 based on authoritative genetic and biomedical databases[1].

Other names
LINC00445
02

Mechanism of action

Not applicable (no direct-acting drugs known for this target as of current literature).

03

Biological functions

Gene expression regulation (including transcriptional, post-transcriptional and chromatin modulation)Potential involvement in cell proliferation, survival, and apoptosis regulation (typical lincRNA functions, though specific roles for LINC00445 require further characterization; general functional assignment from related lincRNAs)
04

Disease associations

Cancer (studied in context of lung cancer and possibly other types, as a biomarker and candidate therapeutic target)Other (lncRNAs/lincRNAs may be implicated in diverse diseases but cancer is primary for LINC00445)
05

Safety considerations

No specific safety concerns reported for targeting LINC00445, but as with all lncRNA targets, challenges include off-target effects, tissue specificity, and delivery methods for therapeutics that modulate RNA molecules
06

Biomarkers

LINC00445 itself is reported as a potential diagnostic biomarker for lung cancer and possibly other cancer types, as suggested by its inclusion in lncRNA panels that discriminate tumor from normal tissue with high sensitivity and specificity

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 445 (LINC00445).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 445 (LINC00445).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call